IDiyas

For the Inventor, By the Inventor

New York, NY, United States of America

Kimberly Vanover

USPTO Granted Patents = 24 

 

 

Average Co-Inventor Count = 4.1

ph-index = 12

Forward Citations = 479(Granted Patents)


Company Filing History:

goldMedal24 out of 172 
 
Intra-cellular Therapies, Inc.
 patents

Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents
1. 12440489 - Organic compounds (2025-10-14),
2. 12410195 - Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders (2025-09-09),
3. 12325726 - Organic compounds (2025-06-10),
4. 12195463 - Organic compounds (2025-01-14),
5. 12194042 - Uses (2025-01-14),
6. 12173004 - Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugs (2024-12-24),
7. 12122792 - Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders (2024-10-22),
8. 12090155 - Methods (2024-09-17),
9. 11958852 - Compounds and methods (2024-04-16),
10. 11844757 - Organic compounds (2023-12-19),
11. 11773095 - Organic compounds (2023-10-03),
12. 11753419 - 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders (2023-09-12),
13. 11427587 - Organic compounds (2022-08-30),
14. 11376249 - Organic compounds (2022-07-05),
15. 11124514 - Compositions and methods (2021-09-21),

Title: Celebrating the Innovation and Contributions of Kimberly Vanover

Introduction: Kimberly Vanover is a prominent inventor based in New York, NY, whose work has significantly impacted the pharmaceutical industry. With an impressive portfolio of 20 patents, Vanover has dedicated her career to advancing medical treatments through innovative chemical compounds and compositions.

Latest Patents: Among her most recent inventions, Vanover has developed novel organic compounds. One notable patent pertains to a specific enantiomer of a substituted heterocycle fused gamma-carboline, which is designed for use as a pharmaceutical composition in treating diseases involving the 5-HT receptor and the dopamine D and D receptor signaling systems. Additionally, she has created pharmaceutical compositions comprising heterocycle fused gamma-carboline prodrugs, aimed at addressing conditions related to the 5-HT receptor, serotonin transporter (SERT), dopamine receptors, and the μ-opioid receptor. These inventions demonstrate her commitment to addressing complex medical challenges through innovative chemistry.

Career Highlights: Kimberly Vanover holds a significant position at Intra-Cellular Therapies, Inc., where she applies her expertise to develop cutting-edge solutions in the biotechnology sector. Her contributions have not only led to advancements in pharmaceutical compositions but also paved the way for new methods in treating various neurological and psychological conditions.

Collaborations: Vanover collaborates with esteemed colleagues such as Sharon Mates and Robert E. Davis, showcasing a collaborative spirit that enhances her innovative efforts. Together, they work towards common goals in research and development, amplifying their impact within the medical community.

Conclusion: Kimberly Vanover's innovative spirit and dedication to her work have made her a vital figure in the field of pharmaceuticals. With her extensive patent portfolio and partnerships, she continues to push the boundaries of science and technology, helping to develop effective treatments that can improve the quality of life for countless individuals. Her journey is a testament to the importance of creativity and collaboration in driving meaningful advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…